Blood compatibility studies of Swarna bhasma (gold bhasma), an Ayurvedic drug.

Willi Paul, Chandra Prakash Sharma
{"title":"Blood compatibility studies of Swarna bhasma (gold bhasma), an Ayurvedic drug.","authors":"Willi Paul,&nbsp;Chandra Prakash Sharma","doi":"10.4103/0974-7788.83183","DOIUrl":null,"url":null,"abstract":"<p><p>Swarna bhasma (gold bhasma) preparations are widely utilized as therapeutic agents. However, in vitro biological evaluations of bhasma preparations are needed along with the physicochemical characterization for present day standardization of metallic bhasma preparations to meet the criteria that supports its use. Therefore, an attempt has been made to evaluate the protein adsorption, blood compatibility and complement activation potential of two batches of Swarna bhasma preparation, along with its physicochemical characterization. The particle size, morphology, elemental analysis, and in vitro cytotoxicity were evaluated initially. Red blood cell hemolysis, aggregation studies with blood cells, protein adsorption, complement C3 adsorption, platelet activation and tight junction permeability in Caco-2 cell line were investigated. The Swarna bhasma preparations with a crystallite size of 28-35 nm did not induce any blood cell aggregation or protein adsorption. Activation potential of these preparations towards complement system or platelets was negligible. These particles were also non-cytotoxic. Swarna bhasma particles opened the tight junctions in Caco-2 cell experiments. The results suggest the application of Swarna bhasma preparations as a therapeutic agent in clinical medicine from the biological safety point of view.</p>","PeriodicalId":88901,"journal":{"name":"International journal of Ayurveda research","volume":"2 1","pages":"14-22"},"PeriodicalIF":0.0000,"publicationDate":"2011-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.4103/0974-7788.83183","citationCount":"62","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International journal of Ayurveda research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4103/0974-7788.83183","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 62

Abstract

Swarna bhasma (gold bhasma) preparations are widely utilized as therapeutic agents. However, in vitro biological evaluations of bhasma preparations are needed along with the physicochemical characterization for present day standardization of metallic bhasma preparations to meet the criteria that supports its use. Therefore, an attempt has been made to evaluate the protein adsorption, blood compatibility and complement activation potential of two batches of Swarna bhasma preparation, along with its physicochemical characterization. The particle size, morphology, elemental analysis, and in vitro cytotoxicity were evaluated initially. Red blood cell hemolysis, aggregation studies with blood cells, protein adsorption, complement C3 adsorption, platelet activation and tight junction permeability in Caco-2 cell line were investigated. The Swarna bhasma preparations with a crystallite size of 28-35 nm did not induce any blood cell aggregation or protein adsorption. Activation potential of these preparations towards complement system or platelets was negligible. These particles were also non-cytotoxic. Swarna bhasma particles opened the tight junctions in Caco-2 cell experiments. The results suggest the application of Swarna bhasma preparations as a therapeutic agent in clinical medicine from the biological safety point of view.

Abstract Image

Abstract Image

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
阿育吠陀药物斯瓦纳巴什玛(金巴什玛)的血液相容性研究。
Swarna bhasma(金bhasma)制剂被广泛用作治疗剂。然而,为了实现金属巴斯马制剂的标准化,需要对巴斯马制剂进行体外生物学评价和物理化学表征,以满足支持其使用的标准。因此,本研究试图对两批丝瓦那玛制剂的蛋白质吸附、血液相容性和补体活化电位进行评价,并对其理化性质进行表征。初步评估了颗粒大小、形态、元素分析和体外细胞毒性。研究了Caco-2细胞系红细胞溶血、血细胞聚集、蛋白吸附、补体C3吸附、血小板活化和紧密连接通透性。晶体大小为28-35 nm的Swarna bhasma制剂未诱导任何血细胞聚集或蛋白质吸附。这些制剂对补体系统或血小板的激活电位可以忽略不计。这些颗粒也没有细胞毒性。在Caco-2细胞实验中,Swarna bhasma粒子打开了紧密连接。结果提示,从生物安全性的角度出发,缬草制剂可作为一种治疗药物应用于临床医学。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
A comprehensive review of Pāṭhabheda (variant readings) in Carakasaṁhitā Vaidya Saadhana: Dharmaparo Bhavet (act righteously) Artificial intelligence in the sector of Ayurveda: Scope and opportunities Use of Ayush measures and advocacies by Ayush practitioners and health seekers for the prevention of coronavirus disease-19: Cross-sectional analysis of an application-based data Preparation and preliminary physicochemical profile of Kaphaketu rasa
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1